Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands
Book Now
Menu
Book
keyboard_arrow_right

Nov 6- Obesity Science & Innovation Europe Post-Event Symposium - Europe/Amsterdam

keyboard_arrow_leftSearch & Filter
search
Nov 6- Obesity Science & Innovation Europe Post-Event Symposium - Europe/Amsterdam
search
Showing 1 of 1 Streams
08:00 - 08:30
Registration
08:30 - 08:40
Obesity Science & Innovation Europe Welcome
  • Kaitlin Dailey - Senior Conference Producer, Obesity Science & Innovation, Informa Connect
08:40 - 08:45
Chair
08:45 - 09:15
Keynote Presentation: Decoding The Future of Obesity Care: The Signals Worth Paying Attention To
  • Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
09:15 - 10:05
Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape
  • Annagret Van Der Aaa - CEO, Cantonix Therapeutics
  • Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
  • Steffen-Sebastian Bolz - CSO, Aphaia Pharma
  • Saleha Patel - Head of Pipeline and Commercialization Strategy, Constructive Bio
10:05 - 10:35
Morning Break
Showing 1 of 1 Streams
10:35 - 10:40
Chair
10:40 - 11:05
Presentation: Exploring A Selective Amylin Receptor Agonist for Metabolic Disease
  • Gabe Smolarz - VP Medical Affairs, Zealand Pharma
11:05 - 11:25
The Obesity Multi-Omic Atlas: Driving Target Discovery
  • Jeremie Boucher - SVP, Head of Metabolic Disease, Evotec
11:25 - 11:50
Presentation: Genetically-Validated INHBE Silencing with SLN098 siRNA for Enhanced Fat Loss and Lean Mass Preservation
  • Lucas Bethge, Ph.D. - VP, Group Leader Chemistry, Silence Therapeutics
11:50 - 12:15
Presentation: Energy Expenditure Modulation as an Emerging Therapeutic Strategy for Obesity
  • Martin Hey-Mogensen - Scientific Director, Emerging Obesity Mechanism, The Energy Expenditure Group, Novo Nordisk
12:15 - 13:25
Lunch Break
Showing 1 of 1 Streams
13:25 - 13:30
Chair
13:30 - 13:50
Presentation: Engineering Advanced GLP-1 Peptides Through Targeted Site-Specific Modifications
  • Robert Salmon - Head of Bioprocess, Constructive Bio
13:50 - 14:10
Presentation: Investigating FKBPL as an Emerging Metabolic Target in Obesity
  • Stephanie Annett - Senior Lecturer, RCSI
14:10 - 14:30
Presentation: Enteroendocrine Cell Activation via Beaded Oral Glucose: A Multi-Hormonal Approach to Metabolic Regulation
  • Steffen-Sebastian Bolz - CSO, Aphaia Pharma
14:30 - 14:50
Presentation: Translational Medicine at the Crossroads of Obesity and Type 2 Diabetes: From Disease Mechanisms to Precision Therapeutics
  • Farhad Rezaee - Principle Investigator/ Project Leader, Erasmus Medical Center Rotterdam
14:50 - 15:10
Presentation: First-in-Class Small Molecule Targeting Adipocyte Futile Cycling for Weight Loss
  • Joanne Hsieh, PhD - Head of Metabolism, Gordian Biotechnology
15:10 - 15:40
Afternoon Break
Showing 1 of 1 Streams
15:40 - 16:05
Keynote Presentation: The Missing Signal in Obesity Care: Turning Everyday Patient Data into Better Clinical Conversations
  • Marcello Duhalde - CGO, Smart Patient
16:05 - 16:30
Keynote Presentation: Weight A Minute: The Patient Perspective
  • Natasja Wijling - Board Member & Patient Advocate, Dutch Association for Overweight & Obesity (NVOO)
Main Conference Day 3
Filter
Streams
Formats
Choose Day